Fierce Healthcare September 15, 2021
Swift Medical, a startup that built an app for remote wound care, is expanding into technology to support decentralized clinical trials, taking on a more than $44 billion market that’s steadily growing.
The company recently rolled out a digital imaging platform used by medical and pharmaceutical researchers to analyze skin and wound conditions remotely in virtual trials. The technology, called Swift Scientific, provides research-grade clinical imaging to support decentralized clinical trials and turns a smartphone into a medical-grade imaging device, according to Carlo Perez, co-founder and CEO of Swift Medical.
Because patients are now doing more trials at home, study coordinators have had trouble tracking skin side effects remotely or trusting patients to conduct adequate analysis and recording on themselves.
...Today's Sponsors
Today's Sponsor